Anssi Auvinen

University of Tampere

Finland

Research Interests

Explore related searches

Professors in Finland

Contact this professor

ORCID

Google Scholar

Academic Page

Articles (30)

Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000–2021

Article Link

Year:

2025

Do differences in secondary treatment explain mortality impact of prostate cancer screening?

Article Link

Year:

2025

Association of prostate‐specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

Article Link

Year:

2025

Cancer risk due to ingestion of naturally occurring radionuclides through drinking water

Article Link

Year:

2025

Searching for a serial killer on a hospital ward

Article Link

Year:

2025

Childhood acute leukemia and type 1 diabetes in children

Article Link

Year:

2025

Clustering of childhood acute leukemia in Finland

Article Link

Year:

2025

Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml

Article Link

Year:

2025

Method of detection, determinants and subsequent treatments for breast, cervical and prostate cancers in Edo–Benin, Nigeria

Article Link

Year:

2025

Risk factors for low-risk prostate cancer

Article Link

Year:

2025

Regression calibration of self-reported mobile phone use to optimize quantitative risk estimation in the COSMOS study

Article Link

Year:

2024

Headache in the international cohort study of mobile phone use and health (COSMOS) in the Netherlands and the United Kingdom

Article Link

Year:

2024

Mobile phone use and brain tumour risk – COSMOS, a prospective cohort study

Article Link

Year:

2024

Education and employment among patients with childhood-onset epilepsy in adulthood: A population-based cohort study

Article Link

Year:

2024

Risk of Clinically Significant Prostate Cancer after a Nonsuspicious Prostate MRI—A Comparison with the General Population

Article Link

Year:

2024

Early detection of clinically significant prostate cancer: protocol summary and statistical analysis plan for the ProScreen randomised trial

Article Link

Year:

2024

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

Article Link

Year:

2024

Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study

Article Link

Year:

2024

Do men adapt to lower urinary tract symptoms? An 11-year longitudinal study of male urinary urgency and associated bother

Article Link

Year:

2024

Do LUTS Predict Mortality? An Analysis Using Random Forest Algorithms

Article Link

Year:

2024

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

Article Link

Year:

2023

Missingness in the expanded prostate cancer index short form (EPIC-26) – prevalence, patterns, and explanatory factors

Article Link

Year:

2023

First diagnostic results from Gothenburg-2 screening trial

Article Link

Year:

2023

Dual direction associations between common autoimmune diseases and leukemia among children and young adults

Article Link

Year:

2023

Residential mobility and childhood inflammatory bowel disease

Article Link

Year:

2023

Antidiabetic drugs, glycemic control and risk of benign prostatic hyperplasia

Article Link

Year:

2023

Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL

Article Link

Year:

2023

Cancer incidence among Chernobyl cleanup workers from Estonia: A 34‐year follow‐up

Article Link

Year:

2023

Increased cardiovascular disease risk after exposure to low dose radiation

Article Link

Year:

2023

Suicide and other causes of death among Chernobyl cleanup workers from Estonia, 1986 − 2020: an update

Article Link

Year:

2023

Collaborators (18)

Teemu J. Murtola

FINLAND

Jack A. Schalken

NETHERLANDS

Alex Asiimwe

UNITED KINGDOM

Joachim Schuz

Head of Section

FRANCE

Susan Evans Axelsson

Lund University

SWEDEN

Jaakko Nevalainen

University of Tampere

FINLAND

Aino Siltari

University of Helsinki

FINLAND

Giorgio Tettamanti

Karolinska Institutet

SWEDEN

Jonne Åkerla

University of Tampere

FINLAND

Maria Feychting

Karolinska Institutet

SWEDEN

Kimmo Taari

University of Helsinki

FINLAND

Atte Nikkilä

University of Tampere

FINLAND

Ilkka Pietilä

University of Helsinki

FINLAND

Ola Bratt

Professor

University of Gothenburg

SWEDEN

Mika Helminen

University of Tampere

FINLAND

Antti Rannikko

University of Helsinki

FINLAND

Jani Raitanen

University of Tampere

FINLAND

John D. Boice

Vanderbilt University Medical Center

UNITED STATES

Anssi Auvinen

Research Interests

Explore related searches

Contact this professor

Articles (30)

Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000–2021

Do differences in secondary treatment explain mortality impact of prostate cancer screening?

Association of prostate‐specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

Cancer risk due to ingestion of naturally occurring radionuclides through drinking water

Searching for a serial killer on a hospital ward

Childhood acute leukemia and type 1 diabetes in children

Clustering of childhood acute leukemia in Finland

Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml

Method of detection, determinants and subsequent treatments for breast, cervical and prostate cancers in Edo–Benin, Nigeria

Risk factors for low-risk prostate cancer

Regression calibration of self-reported mobile phone use to optimize quantitative risk estimation in the COSMOS study

Headache in the international cohort study of mobile phone use and health (COSMOS) in the Netherlands and the United Kingdom

Mobile phone use and brain tumour risk – COSMOS, a prospective cohort study

Education and employment among patients with childhood-onset epilepsy in adulthood: A population-based cohort study

Risk of Clinically Significant Prostate Cancer after a Nonsuspicious Prostate MRI—A Comparison with the General Population

Early detection of clinically significant prostate cancer: protocol summary and statistical analysis plan for the ProScreen randomised trial

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study

Do men adapt to lower urinary tract symptoms? An 11-year longitudinal study of male urinary urgency and associated bother

Do LUTS Predict Mortality? An Analysis Using Random Forest Algorithms

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

Missingness in the expanded prostate cancer index short form (EPIC-26) – prevalence, patterns, and explanatory factors

First diagnostic results from Gothenburg-2 screening trial

Dual direction associations between common autoimmune diseases and leukemia among children and young adults

Residential mobility and childhood inflammatory bowel disease

Antidiabetic drugs, glycemic control and risk of benign prostatic hyperplasia

Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL

Cancer incidence among Chernobyl cleanup workers from Estonia: A 34‐year follow‐up

Increased cardiovascular disease risk after exposure to low dose radiation

Suicide and other causes of death among Chernobyl cleanup workers from Estonia, 1986 − 2020: an update

Collaborators (18)

Teemu J. Murtola

Jack A. Schalken

Alex Asiimwe

Joachim Schuz

Susan Evans Axelsson

Jaakko Nevalainen

Aino Siltari

Giorgio Tettamanti

Jonne Åkerla

Maria Feychting

Kimmo Taari

Atte Nikkilä

Ilkka Pietilä

Ola Bratt

Mika Helminen

Antti Rannikko

Jani Raitanen

John D. Boice

How do I reach out?

Meet Kite AI